Patent classifications
Y10S977/811
Magnetic particle control and visualization
Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.
Nanometer sized structures grown by pulsed laser deposition
Nanometer sized materials can be produced by exposing a target to a laser source to remove material from the target and deposit the removed material onto a surface of a substrate to grow a thin film in a vacuum chamber.
IRON OXIDE MAGNETIC PARTICLE COMPOSITIONS AND METHODS OF SYNTHESIZING SAME
Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.
COMPOSITIONS OF MATTER COMPRISING SUSPENDED NANOPARTICLES AND RELATED METHODS
A composition of matter includes a liquid and nanoparticles suspended in the liquid. The nanoparticles each include silica, alumina, and an organosilicon functional group having a molecular weight of at least 200. A method includes functionalizing a surface of nanoparticles with an organosilicon functional group and dispersing the nanoparticles in a liquid to form a suspension. The functional group has a molecular weight of at least 200. The nanoparticles each include silica and alumina at a surface thereof.
Microparticles and apparatus for smart ink production
A smart ink, comprising microparticles, with each microparticle comprising: a) an exterior shell; b) a liquid encapsulated within the shell; and c) a Janus microparticle suspended in the liquid, wherein the Janus microparticle either comprises: i) two or more distinct assemblies of particles; or ii) a core loaded with particles, the core having a first surface portion and a second surface portion that is functionally distinct from the first surface portion. An apparatus and method for production of the microparticles are also provided.
Devices for controlling magnetic nanoparticles to treat fluid obstructions
A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In one embodiment, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.
Compositions of matter comprising suspended nanoparticles and related methods
A composition of matter includes a liquid and nanoparticles suspended in the liquid. The nanoparticles each include silica, alumina, and an organosilicon functional group having a molecular weight of at least 200. A method includes functionalizing a surface of nanoparticles with an organosilicon functional group and dispersing the nanoparticles in a liquid to form a suspension. The functional group has a molecular weight of at least 200. The nanoparticles each include silica and alumina at a surface thereof.
Biomimetic limb and robot using the same
The disclosure relates to a biomimetic limb and robot using the same. The biomimetic limb includes: an arm and a biomimetic hand connected to the arm and including at least one biomimetic finger. The biomimetic finger includes a carbon nanotube layer and a vanadium dioxide layer (VO.sub.2) layer stacked with each other. Because the drastic, reversible phase transition of VO.sub.2, the biomimetic finger has giant deformation amplitude and fast response. An robot using the biomimetic limb is also provided.
Detection of fluidic current generated by rotating magnetic particles
Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.
Method for preparing magnetic iron oxide-graphene composite
The present invention relates to a method for preparing a magnetic iron oxide-graphene composite, a magnetic iron oxide-graphene composite prepared thereby and a composition for electromagnetic wave shielding including the same, and since graphene is prepared from a stage 1-GIC using FeCl.sub.3, magnetic particles in the form of FeO.sub.x are naturally formed on the surface of graphene during the preparation process. In addition, a magnetic material is formed on the surface of graphene while the defects of graphene are minimized, and thus the magnetic iron oxide-graphene composite prepared according to the present invention can be useful as an electromagnetic wave absorber.